Simple Summary In view of the recent advances in immunoncology, we want to reevaluate
and summarize the role of the immune system in malignant pleural mesothelioma (MPM) …

Simple Summary Tumor immune microenvironment is an important structural component of
malignant pleural mesothelioma that contributes to disease growth support and progression …

Simple Summary Malignant pleural mesothelioma is a rare and aggressive tumour,
associated with asbestos exposure. Current therapeutic approaches for malignant …

Malignant pleural mesothelioma (MPM) is an aggressive, primary pleural malignancy with
poor prognosis, hypothesized to originate from a chronic inflammatory state within the …

Background: Malignant pleural mesothelioma (MPM) represents a fatal disease with high
aggressiveness, and limited biomarkers have yet been identified for MPM. The present study …

Malignant pleural mesothelioma (MPM) is a rare, aggressive cancer of the pleural surface,
associated with asbestos exposure, whose incidence is still growing in some areas of the …

Introduction A comprehensive analysis of the immune cell infiltrate collected from pleural
fluid and from biopsy specimens of malignant pleural mesothelioma (MPM) may contribute …

Introduction Chronic inflammation plays a key role in the pathogenesis of malignant pleural
mesothelioma (MPM) as a result of asbestos exposure. Biomarkers of systemic inflammation …

Background Prediction of prognosis is a key step of malignant pleural mesothelioma (MPM)
management and treatment assignment. Aim of this study was to identify simple prognostic …

Malignant pleural mesothelioma (MPM) is a lethal thoracic malignancy whose incidence is
still increasing worldwide. MPM is characterized by frequent inactivation of tumor …